INDOAMIN

Indo Amines Share Price

₹171.10 +2.05 (1.21%)

28 Dec, 2024 03:25

SIP TrendupStart SIP in INDOAMIN

Start SIP

Performance

  • Low
  • ₹168
  • High
  • ₹174
  • 52 Week Low
  • ₹107
  • 52 Week High
  • ₹248
  • Open Price₹171
  • Previous Close₹169
  • Volume150,611

Investment Returns

  • Over 1 Month + 0.96%
  • Over 3 Month -23.81%
  • Over 6 Month + 38.24%
  • Over 1 Year + 32.28%
SIP Lightning

Smart Investing Starts Here Start SIP with Indo Amines for Steady Growth!

Invest Now

Indo Amines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24
  • PEG Ratio
  • 54.7
  • Market Cap Cr
  • 1,242
  • P/B Ratio
  • 4.7
  • Average True Range
  • 8.68
  • EPS
  • 7.33
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 0.98
  • RSI
  • 39.95
  • MFI
  • 54.39

Indo Amines Financials

Indo Amines Technicals

EMA & SMA

Current Price
₹171.10
+ 2.05 (1.21%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹182.16
  • 50 Day
  • ₹183.09
  • 100 Day
  • ₹179.00
  • 200 Day
  • ₹166.40

Resistance and Support

171.04 Pivot Speed
  • R3 180.03
  • R2 177.01
  • R1 174.06
  • S1 168.09
  • S2 165.07
  • S3 162.12

What's your outlook on Indo Amines?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indo Amines Ltd. manufactures and supplies fine chemicals, including fatty amines, aliphatic amines, and specialty chemicals. The company serves industries like pharmaceuticals, textiles, and agriculture, offering high-quality chemical solutions across domestic and international markets.

Indo Amines has an operating revenue of Rs. 981.26 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 6% is okay, ROE of 16% is good. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 83 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indo Amines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-08 Quarterly Results
2024-05-22 Audited Results & Final Dividend
2024-02-09 Quarterly Results
2023-11-09 Quarterly Results
Date Purpose Remarks
2021-02-13 INTERIM Rs.0.50 per share(5%)Interim Dividend
Date Purpose Remarks
2022-01-15 Split Rs.0.00 split from Rs. 10/- to Rs. 5/-.

Indo Amines F&O

Indo Amines Shareholding Pattern

57.25%
0.01%
27.31%
15.43%

About Indo Amines

  • NSE Symbol
  • INDOAMIN
  • BSE Symbol
  • 524648
  • Managing Director & CEO
  • Mr. Vijay B Palkar
  • ISIN
  • INE760F01028

Similar Stocks to Indo Amines

Indo Amines FAQs

Indo Amines share price is ₹171 As on 28 December, 2024 | 03:11

The Market Cap of Indo Amines is ₹1242 Cr As on 28 December, 2024 | 03:11

The P/E ratio of Indo Amines is 24 As on 28 December, 2024 | 03:11

The PB ratio of Indo Amines is 4.7 As on 28 December, 2024 | 03:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23